Mundipharma
Faye Liu is a seasoned HRIS professional with extensive experience, currently serving as a Senior HRIS Supervisor at Mundipharma since January 2017. Liu has led the Interface project from Workday to Vanguard and designed the Workday onboarding process. Previously, Liu held the role of HRIS Supervisor at Mundipharma, managing daily operations for multiple HR systems, including Workday, and contributed to various projects such as custom report design and system testing for Workday LMS. Before this, Liu worked as an HRIS Consultant at 58同城, implementing Workday by leading testing and training efforts. Liu started in the HRIS field at 联想 as an HRIS Specialist, where involvement included Workday implementation and data migration projects. Liu has a Bachelor's degree in Human Resources Management from North China Electric Power University.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.